Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed)
Nov 27 2019
Feb 01 2020
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to establish research network(s) focused on rapidly recruiting a sufficient number of participants to dissect the heterogeneity of the clinical high risk for psychosis (CHR) syndrome so as to predict differential CHR outcomes. Results from these studies will inform future treatment development efforts.